Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MGNX stock hub

MacroGenics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MGNXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

190.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MGNX

In the news

Latest news · MGNX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-86.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-37

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MGNX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001125345
Company name	MacroGenics, Inc.
Country	United States
Country code	US
Cusip	556099109
Employees	293
Employees Change	-48%
Employees Change Percent	-14.08
Enterprise value	$37.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2013-10-10
Isin	US5560991094
Last refreshed	2026-05-10
Market cap	$190.7M
Market cap category	Micro-Cap
Price	$3
Price currency	USD
Rev Per Employee	510,238.91x
Sector	Healthcare
Sic	2834
Symbol	MGNX
Website	https://www.macrogenics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-39.13%
EV Sales Forward	0.46x
EV/Sales	0.25x
FCF yield	-43.5%
P/B ratio	3.42x
P/S ratio	1.28x
PS Forward	2.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-48.72%
EBITDA Margin	-43.93%
Gross margin	-22.53%
Gross Profit	$-33.7M
Net Income	$-74.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-50.36%
Profit Margin	-49.91%
Profit Per Employee	$-254,676
ROA	-17.56
Roa5y	-27.74
ROCE	-34.08
ROE	-86.95
Roe5y	-56.24
ROIC	-37.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-16.48%
Cagr1y	101.44%
Cagr3y	-24.99%
Cagr5y	-37.65%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-0.31x
Revenue Growth Q	113.03x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.54x
Revenue Growth5 Y	7.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.58
Assets	$256.8M
Cash	$189.9M
Current Assets	$219.9M
Current Liabilities	$43.1M
Debt	$36.8M
Debt Equity	$0.66
Equity	$55.6M
Interest Coverage	-8.56
Liabilities	$201.3M
Long Term Assets	$36.9M
Long Term Liabilities	$158.1M
Net Cash	$153.2M
Net Cash By Market Cap	$80.32
Net Cash Growth	-6.73%
Net Debt Equity	$-2.75
Tangible Book Value	$55.6M
Tangible Book Value Per Share	$0.88
WACC	11.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.1
Net Working Capital	$-7.9M
Quick ratio	4.71
Working Capital	$176.8M
Working Capital Turnover	$0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.85%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-83.47%
1Y total return	101.34%
200-day SMA	1.99
3Y total return	-57.81%
50-day SMA	3.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.57%
All Time High	41
All Time High Change	-92.68%
All Time High Date	2014-02-03
All Time Low	0.99
All Time Low Change	203.12%
All Time Low Date	2025-04-07
ATR	0.21
Beta	1.08
Beta1y	1.12
Beta2y	1.91
Ch YTD	86.34
High	3.1
High52	3.88
High52 Date	2026-04-10
High52ch	-22.68%
Low	2.9
Low52	1.19
Low52 Date	2025-06-27
Low52ch	153.17%
Ma50ch	-0.4%
Price vs 200-day SMA	50.83%
RSI	45.41
RSI Monthly	46.46
RSI Weekly	62.42
Sharpe ratio	1.14x
Sortino ratio	2.38
Total Return	-0.85%
Tr YTD	86.34
Tr1m	-10.45%
Tr1w	-4.15%
Tr3m	65.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$6.67
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.55
Earnings Revenue Estimate	15,875,336x
Earnings Revenue Estimate Growth	20.34x
Operating Income	$-72.8M
Operating margin	-48.72
Price target	$5
Price Target Change	$66.67
Price Target Change Top	$122

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,595,943%
Float Percent	87.47%
Shares Insiders	2.58%
Shares Institutions	49.98%
Shares Out	63,560,068
Shares Qo Q	-0%
Shares Yo Y	0.85%
Short Float	5.27%
Short Ratio	3.27
Short Shares	4.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-97.2M
Average Volume	623,322.8x
Bv Per Share	0.88
CAPEX	$-1.9M
Ch10y	-83.47
Ch1m	-10.45
Ch1w	-4.15
Ch1y	101.3
Ch3m	65.75
Ch3y	-57.81
Ch5y	-90.57
Ch6m	119
Change	2.04%
Change From Open	1.35
Close	2.94
Days Gap	0.68
Depreciation Amortization	7,172,000
Dollar Volume	2,442,702
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-72.8M
EBITDA	$-65.7M
EPS	$-1.18
F Score	3
FCF	$-83M
FCF EV Yield	-221.04x
FCF Per Share	$-1.31
Financing CF	69,514,000
Fiscal Year End	December
Founded	2,000
Income Tax	$-672,000
Investing CF	-114,097,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-09
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	2.1
Ma150ch	42.93%
Ma20	3.23
Ma20ch	-7.12%
Net CF	-125,623,000
Next Earnings Date	2026-05-22
Open	2.96
Optionable	Yes
Position In Range	51.28
Post Close	3
Postmarket Change Percent	-0.33
Postmarket Price	$2.99
Ppne	35,520,000
Price Date	2026-05-08
Ptbv Ratio	3.43
Relative Volume	1.31x
Revenue	149,500,000x
SBC By Revenue	9.56x
Share Based Comp	14,286,000
Tax By Revenue	-0.45x
Tr6m	118.98%
Us State	Maryland
Volume	814,234
Z Score	-5.97

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MGNX pay a dividend?

Capital-return profile for this ticker.

Performance

MGNX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MGNX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+50.0%

Float: +87.5% of shares outstanding

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MGNX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.4

Neutral momentum band

Price vs 200-day MA

+50.8%

50/200-day relationship not available

Beta (5Y)

1.08

Moves roughly with the market

Sharpe ratio

1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MGNX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MGNX stock rating?

MacroGenics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MGNX analysis?

The full report lives at /stocks/MGNX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MGNX?

The latest report frames MGNX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MGNX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.